Utility of bronchoalveolar lavage in evaluation of patients with connective tissue diseases.

[1]  B. Keogh,et al.  Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis. , 2015, The American review of respiratory disease.

[2]  K. Kowal,et al.  Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature. , 2010, Seminars in arthritis and rheumatism.

[3]  H. Collard,et al.  Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. , 2009, Chest.

[4]  V. Cottin,et al.  Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis , 2009, European Respiratory Journal.

[5]  K. Antoniou,et al.  Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement , 2009, European Respiratory Journal.

[6]  Karina D. Torralba,et al.  Sarcoidosis and the rheumatologist , 2009, Current opinion in rheumatology.

[7]  A. Wells,et al.  Histopathology and bronchoalveolar lavage. , 2008, Rheumatology.

[8]  A. Wells,et al.  Interstitial lung disease guideline , 2008, Thorax.

[9]  J. Rojas-Serrano,et al.  High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage , 2008, Lupus.

[10]  L. Criswell,et al.  Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. , 2007, Arthritis and rheumatism.

[11]  D. Hansell,et al.  Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. , 2007, Arthritis and rheumatism.

[12]  T. Medsger,et al.  Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.

[13]  E. Kulinskaya,et al.  Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. , 2006, Rheumatology.

[14]  D. Gladman,et al.  Mortality in systemic lupus erythematosus. , 2006, The Journal of rheumatology. Supplement.

[15]  D. Scott,et al.  Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. , 2006, The Journal of rheumatology.

[16]  G. La Torre,et al.  Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis , 2005, Respiratory research.

[17]  A. Nicholson,et al.  Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. , 2005, American journal of respiratory and critical care medicine.

[18]  Y. Shoenfeld,et al.  Infections and SLE , 2005, Autoimmunity.

[19]  R. Elashoff,et al.  Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis. , 2004, Arthritis and rheumatism.

[20]  U. Costabel,et al.  Bronchoalveolar lavage in drug-induced lung disease. , 2004, Clinics in chest medicine.

[21]  J. Biederer,et al.  Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis , 2004, European Radiology.

[22]  J. Biederer,et al.  Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. , 2003, Seminars in arthritis and rheumatism.

[23]  E. Hachulla,et al.  Interstitial lung disease in polymyositis and dermatomyositis. , 2002, Arthritis and rheumatism.

[24]  K. Takabayashi,et al.  Activation of pulmonary T cells in corticosteroid‐resistant and ‐sensitive interstitial pneumonitis in dermatomyositis/polymyositis , 2002, Clinical and experimental immunology.

[25]  A. Nicholson,et al.  Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. , 2002, American journal of respiratory and critical care medicine.

[26]  J. Mcintyre,et al.  APL and renal transplantation A risk assessment , 2002 .

[27]  U. Costabel,et al.  ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias , 2002, European Respiratory Journal.

[28]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[29]  J. Lynch,et al.  Drug-induced pneumonitis: the role of methotrexate. , 2001, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[30]  L. Czirják,et al.  Alveolitis may persist during treatment that sufficiently controls muscle inflammation in myositis , 2001, Rheumatology International.

[31]  B. Fessler,et al.  Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. , 2000, Chest.

[32]  I. Griffiths,et al.  Ten year follow up of pulmonary function in patients with primary Sjögren's syndrome , 2000, Annals of the rheumatic diseases.

[33]  R. Wise,et al.  Cyclophosphamide Is Associated with Pulmonary Function and Survival Benefit in Patients with Scleroderma and Alveolitis , 2000, Annals of Internal Medicine.

[34]  M. Keane,et al.  Pleuropulmonary manifestations of systemic lupus erythematosus , 2000, Rheumatic diseases clinics of North America.

[35]  M. Arakawa,et al.  Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia , 1999, Respirology.

[36]  R. Matthay,et al.  Pulmonary manifestations of Sjögren's syndrome. , 1998, Clinics in chest medicine.

[37]  B. Wallaert,et al.  Pulmonary involvement in polymyositis and in dermatomyositis. , 1998, The Journal of rheumatology.

[38]  M. Petri,et al.  Infection in systemic lupus erythematosus. , 1998, Rheumatic diseases clinics of North America.

[39]  F. Salaffi,et al.  A longitudinal study of pulmonary involvement in primary Sjögren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography. , 1998, British journal of rheumatology.

[40]  T. Rochat,et al.  Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. , 1997, The European respiratory journal.

[41]  E. Gabbay,et al.  Interstitial lung disease in recent onset rheumatoid arthritis. , 1997, American journal of respiratory and critical care medicine.

[42]  L. Jara,et al.  Pulmonary hemorrhage in systemic lupus erythematosus , 1997, Lupus.

[43]  M. Zamora,et al.  Diffuse Alveolar Hemorrhage and Systemic Lupus Erythematosus: Clinical Presentation, Histology, Survival, and Outcome , 1997, Medicine.

[44]  Ò. Miró,et al.  Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. , 1996, The Journal of rheumatology.

[45]  C. V. Strimlan.  Interstitial lung disease and primary Sjögren's syndrome: clinical-pathological evaluation and response to treatment. , 1996, American journal of respiratory and critical care medicine.

[46]  K. Aho,et al.  Mortality in rheumatoid arthritis. , 1995, Seminars in arthritis and rheumatism.

[47]  T. Medsger,et al.  Severe restrictive lung disease in systemic sclerosis. , 1994, Arthritis and rheumatism.

[48]  D. Postma,et al.  Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus (SLE) , 1993, Clinical and experimental immunology.

[49]  H. Schumacher,et al.  Pulmonary alveolar hemorrhage in systemic lupus erythematosus. , 1993, Seminars in arthritis and rheumatism.

[50]  G. Hughes,et al.  Systemic Lupus Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of 1,000 Patients , 1993 .

[51]  S. Constantopoulos,et al.  Alveolitis correlates with clinical pulmonary involvement in primary Sjögren's syndrome. , 1991, Chest.

[52]  O. Sharma,et al.  A long-term study of interstitial lung disease in systemic lupus erythematosus. , 1990, Seminars in arthritis and rheumatism.

[53]  B. Bresnihan,et al.  Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease. , 1990, Thorax.

[54]  K. Miller,et al.  Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. , 1990, The American journal of medicine.

[55]  H. Klech.  Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. , 1989, The European respiratory journal.

[56]  B. Wallaert,et al.  Lymphocyte subpopulations in bronchoalveolar lavage in Sjögren's syndrome. Evidence for an expansion of cytotoxic/suppressor subset in patients with alveolar neutrophilia. , 1987, Chest.

[57]  B. Wallaert,et al.  Subclinical lung inflammation in primary Sjögren's syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. , 1987, Arthritis & Rheumatism.

[58]  B. Wallaert,et al.  Alveolar macrophage dysfunction in systemic lupus erythematosus. , 1987, The American review of respiratory disease.

[59]  N. Miyasaka,et al.  Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome. , 1986, Clinical and experimental immunology.

[60]  B. Wallaert,et al.  Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. , 1986, The American review of respiratory disease.

[61]  B. Dickey,et al.  Pulmonary disease in polymyositis/dermatomyositis. , 1984, Seminars in arthritis and rheumatism.

[62]  G. Hutchins,et al.  The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. , 1981, The American journal of medicine.

[63]  E. Lewis,et al.  PULMONARY HEMORRHAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1978, Medicine.

[64]  E. Rosenow,et al.  Pulmonary manifestations of Sjögren's syndrome. , 1976, Chest.

[65]  K. Brown,et al.  Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. , 2008, Chest.

[66]  R. Elashoff,et al.  Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. , 2008, American journal of respiratory and critical care medicine.

[67]  H. Uchiyama,et al.  Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. , 2005, The Journal of rheumatology.

[68]  T. Colby,et al.  The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. , 2002, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[69]  S. Zinkgraf,et al.  Lower respiratory tract abnormalities in rheumatoid interstitial lung disease. Potential role of neutrophils in lung injury. , 1987, The American review of respiratory disease.

[70]  R. S. Gordon,et al.  Incidence of infection in systemic lupus erythematosus. , 1974, Arthritis and rheumatism.